Compounds > levofloxacin
Page last updated: 2024-09-04

levofloxacin and Graft vs Host Disease

levofloxacin has been researched along with Graft vs Host Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Courter, JD; Dandoy, CE; Davies, SM; Gardner, JC; Teusink-Cross, A1
Kaufmann, M; Knabbe, C; Seibold, E; Splettstoesser, W; Weile, J1
Chang, FY; Chang, PY; Chao, TY; Chen, YC; Dai, MS; Ho, CL; Kao, WY; Lin, JC; Wang, CH; Wu, YY1
Bateman, AC; Clarridge, J; Garvin, K; Greenbaum, A; Grim, J; Liu, AW1

Other Studies

4 other study(ies) available for levofloxacin and Graft vs Host Disease

ArticleYear
Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients.
    Transplantation and cellular therapy, 2022, Volume: 28, Issue:3

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Child; Child, Preschool; Clostridium Infections; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Levofloxacin; Retrospective Studies; Young Adult

2022
Treatment of tularemia in patient with chronic graft-versus-host disease.
    Emerging infectious diseases, 2013, Volume: 19, Issue:5

    Topics: Anti-Bacterial Agents; Chronic Disease; Doxycycline; Francisella tularensis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Tularemia

2013
Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2018, Volume: 51, Issue:1

    Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Bacteremia; Drug Resistance, Multiple, Bacterial; Female; Graft vs Host Disease; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Retrospective Studies; Risk Factors; Taiwan; Transplant Recipients; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Young Adult

2018
Cutaneous phaeohyphomycosis in a hematopoietic stem cell transplant patient caused by Alternaria rosae: First case report.
    Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:3

    Topics: Acute Kidney Injury; Acyclovir; Aged; Alternaria; Alternariosis; Antibiotic Prophylaxis; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Graft vs Host Disease; Hand; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Levofloxacin; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Paranasal Sinuses; Phaeohyphomycosis; Pneumonia; Prednisone; Primary Myelofibrosis; Respiratory Insufficiency; Spores, Fungal; Transplantation, Homologous; Triazoles; Voriconazole

2017